References
- Krulich L, Dhariwal A P, McCann SM. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. Endocrinology 1968; 83: 783–90
- Brazeau P, Vale W, Burgus R, et al. Hypothalamic polypetide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973; 179: 77–9
- Reichlin S. Somatostatin (part I). N Engl J Med 1983; 309: 1495–501
- Reichlin S. Somatostatin (part II). N Engl J Med 1983; 309: 1556–63
- Lewin M JM. Somatostatin receptors. Scand J Gastroenterol 1986; 42–7, Suppl 119
- Lucey MR. Endogenous somatostatin and the gut. Gut 1986; 27: 451–7
- Iversen LL. Non opioid neuropeptides in mammalian CNS. Ann Rev Pharmacol Toxicol 1983; 23: 1–5
- Reubi J C, Landolt AM. High density of somatostatin receptors in pituitary tumors from acromegalic patients. J Clin Endocrinol Metab 1984; 59: 1148–51
- Reubi J C, Lang W, Maurer R, et al. Distribution and biochemical characterization of somatostatin receptors in tumors of the human central nervous system. Cancer Res 1987; 47: 5758–64
- Reubi J C, Maurer R, von Werder K, et al. Somatostatin receptors in human endocrine tumors. Cancer Res 1987; 47: 551–8
- Sagman U, Mullen J B, Kovacs K, et al. Identification of somatostatin receptors in human small cell lung carcinoma. Cancer 1990; 66: 2129–33
- Reubi J C, Kvols L, Krenning E, et al. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 1990; 39: 78–81
- Reubi J C, Chayvialle J A, Franc B, et al. Somatostatin receptors and somato statin content in medullary thyroid carcinomas. Lab Invest 1991; 64: 567–73
- Mascardo R N, Sherline P. Somatostatin inhibits rapid centrosomal separation and cell proliferation induced by epidermal growth factor. Endocrinology 1982; 111: 1394–7
- Lamberts S WJ, Krenning E P, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrine Rev 1991; 12: 450–82
- Arnold R. Therapeutic strategies in the management of endocrine GEP tumors. Eur J Clin Invest 1990; 20: 82–90
- Arnold R, Neuhaus C, Trautmann ME. Therapie en-dokriner gastroentero-pankreatischer Tumoren mit dem Somatostatin-Analogon Octreotid. Dtsch med Wschr 1992; 117: 1067–71
- Arnold R. Diagnosis and therapy of active endocrine pancreatic tumors Schweiz. Rundschau-Med-Prax. 1994; 828–32
- Hurst R D, Moddlin I M. Use of radiolabeled somatostatin analogs in the identification and treatment of somatostatin receptor-bearing tumors. Digestion 1993; 88–91, Suppl 1